anti pgc1 α Search Results


90
Taiclone Biotech Corporation anti-pgc1α (tcea3326)
Representative western blot and densitometric analysis showing level of <t>PGC1α</t> ( a ), MFN1 ( b ), MFN2 ( c ), OPA1 long form (L-OPA1, 95kD) and short form (S-OPA1, 75kD) ( d ), and DRP1 ( e ) proteins in RMC cells following 0, 30, and 60 μM of bicalutamide treatment for 24 and 48 h. β-Actin is as cytosolic normalization control; HSP60 is as mitochondrial normalization control. Bar graph represents the mean ± SD of triplicate experiments: * p < 0.05, ** p < 0.01 *** p < 0.001 compared to Bic 0 μM at 24 h. ## p < 0.01 compared to Bic 30 μM at 24 h. § p < 0.05, §§ p < 0.01, §§§ p < 0.001 compared to Bic 0 μM at 48 h. p < 0.001 compared to Bic 30 μM at 48 h.
Anti Pgc1α (Tcea3326), supplied by Taiclone Biotech Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pgc1+%CE%B1/anti+pgc1%CE%B1++tcea3326+/pmc08745250-58-34-40
Average 90 stars, based on 1 article reviews
anti-pgc1α (tcea3326) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

94
Bioss pgc1 alpha polyclonal antibody
Representative western blot and densitometric analysis showing level of <t>PGC1α</t> ( a ), MFN1 ( b ), MFN2 ( c ), OPA1 long form (L-OPA1, 95kD) and short form (S-OPA1, 75kD) ( d ), and DRP1 ( e ) proteins in RMC cells following 0, 30, and 60 μM of bicalutamide treatment for 24 and 48 h. β-Actin is as cytosolic normalization control; HSP60 is as mitochondrial normalization control. Bar graph represents the mean ± SD of triplicate experiments: * p < 0.05, ** p < 0.01 *** p < 0.001 compared to Bic 0 μM at 24 h. ## p < 0.01 compared to Bic 30 μM at 24 h. § p < 0.05, §§ p < 0.01, §§§ p < 0.001 compared to Bic 0 μM at 48 h. p < 0.001 compared to Bic 30 μM at 48 h.
Pgc1 Alpha Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pgc1+%CE%B1/PGC1+alpha+Polyclonal+Antibody/bioss___bs-1832r
Average 94 stars, based on 1 article reviews
pgc1 alpha polyclonal antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Wuhan Fine Biotech anti pgc1α antibody
Representative western blot and densitometric analysis showing level of <t>PGC1α</t> ( a ), MFN1 ( b ), MFN2 ( c ), OPA1 long form (L-OPA1, 95kD) and short form (S-OPA1, 75kD) ( d ), and DRP1 ( e ) proteins in RMC cells following 0, 30, and 60 μM of bicalutamide treatment for 24 and 48 h. β-Actin is as cytosolic normalization control; HSP60 is as mitochondrial normalization control. Bar graph represents the mean ± SD of triplicate experiments: * p < 0.05, ** p < 0.01 *** p < 0.001 compared to Bic 0 μM at 24 h. ## p < 0.01 compared to Bic 30 μM at 24 h. § p < 0.05, §§ p < 0.01, §§§ p < 0.001 compared to Bic 0 μM at 48 h. p < 0.001 compared to Bic 30 μM at 48 h.
Anti Pgc1α Antibody, supplied by Wuhan Fine Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+pgc1+%CE%B1/anti+pgc1%CE%B1/10__4103_slash_wjtcm__wjtcm_26_25-44-0-6
Average 86 stars, based on 1 article reviews
anti pgc1α antibody - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


Representative western blot and densitometric analysis showing level of PGC1α ( a ), MFN1 ( b ), MFN2 ( c ), OPA1 long form (L-OPA1, 95kD) and short form (S-OPA1, 75kD) ( d ), and DRP1 ( e ) proteins in RMC cells following 0, 30, and 60 μM of bicalutamide treatment for 24 and 48 h. β-Actin is as cytosolic normalization control; HSP60 is as mitochondrial normalization control. Bar graph represents the mean ± SD of triplicate experiments: * p < 0.05, ** p < 0.01 *** p < 0.001 compared to Bic 0 μM at 24 h. ## p < 0.01 compared to Bic 30 μM at 24 h. § p < 0.05, §§ p < 0.01, §§§ p < 0.001 compared to Bic 0 μM at 48 h. p < 0.001 compared to Bic 30 μM at 48 h.

Journal: Journal of Clinical Medicine

Article Title: Bicalutamide Exhibits Potential to Damage Kidney via Destroying Complex I and Affecting Mitochondrial Dynamics

doi: 10.3390/jcm11010135

Figure Lengend Snippet: Representative western blot and densitometric analysis showing level of PGC1α ( a ), MFN1 ( b ), MFN2 ( c ), OPA1 long form (L-OPA1, 95kD) and short form (S-OPA1, 75kD) ( d ), and DRP1 ( e ) proteins in RMC cells following 0, 30, and 60 μM of bicalutamide treatment for 24 and 48 h. β-Actin is as cytosolic normalization control; HSP60 is as mitochondrial normalization control. Bar graph represents the mean ± SD of triplicate experiments: * p < 0.05, ** p < 0.01 *** p < 0.001 compared to Bic 0 μM at 24 h. ## p < 0.01 compared to Bic 30 μM at 24 h. § p < 0.05, §§ p < 0.01, §§§ p < 0.001 compared to Bic 0 μM at 48 h. p < 0.001 compared to Bic 30 μM at 48 h.

Article Snippet: The membranes were then incubated for 16 h at 4 °C with anti-Tomm 20 (GTX133756), anti-NOX4 (GTX121929) and anti-Mitofusin 1 (MFN1) (GTX133351) (GeneTex, Inc., Irvine, CA, USA), anti-NDUFB8 (tccua 57905), anti-SIRT1 (tcea19648), anti-SIRT3 (tcna3378), anti-PGC1α (tcea3326), anti-Mitofusin 2 (MFN2) (tcea20884) (Taiclone Biotech Co., Taipei, Taiwan), anti-SOD2 (Cell Signaling Technology, Danvers, MA, USA), anti-OPA1 (NBP2-59770, Novus Biologicals, Centennial, CO, USA), and anti-DRP1 (sc-271583, Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA).

Techniques: Western Blot